line

News

Innovative Science Affordable Medicine

NEWS

MOU Signed with Korea Institute of Radiological Medical Sciences(KIRAMS)

Author
admin
Date
2019-03-08 10:39
Views
358


MOU Signed with Korea Institute of Radiological Medical Sciences(KIRAMS)



한국원자력의학원

Chairperson of KIRAM Mi-Sook Kim(left), CEO and president of WMBIO Dong-Hoon Jin (right)


Wellmarker Bio (WMBIO), a Korean biomarker based anti-cancer drug development company and the Korea Institute of Radiological Medical Sciences (KIRAMS) had signed an MOU on February 27, 2019 for mutual cooperation on new drug development and technology commercialization. KIRAMS will focus on developing novel anti-cancer drug and radiation therapy with WMBIO. Mainly, it will conduct joint academic research, manpower exchange, co-develop education program, share information and laboratory facilities with WMBIO BASED ON KIRAM’s science technology medical center.


“Through this MOU agreement, we will accelerate in developing new anti-cancer drugs with Wellmarker Bio’s preeminent technology and KIRAMS’s radiation therapy technology for cancer.” Said the Chairperson of KIRAM, Mi-Sook Kim.